Biotech’s virtual JPM conference was a big deal. But, actually, there wasn’t one

Gilead's cancer ambitions, drug makers continue to mine Covid-19 and potential HIV breakthroughs in a wrap-up of the 40th annual J.P. Morgan Healthcare Conference.

Click to view original post